314 related articles for article (PubMed ID: 23126058)
21. Overexpression of epithelial macrophage colony-stimulating factor (CSF-1) and CSF-1 receptor: a poor prognostic factor in epithelial ovarian cancer, contrasted with a protective effect of stromal CSF-1.
Chambers SK; Kacinski BM; Ivins CM; Carcangiu ML
Clin Cancer Res; 1997 Jun; 3(6):999-1007. PubMed ID: 9815777
[TBL] [Abstract][Full Text] [Related]
22. Malignant mixed mesodermal tumor in a young woman with polycystic ovary syndrome. A case report.
Karabakhtsian R; Heller DS; Singhal P; Sama J
J Reprod Med; 2002 Nov; 47(11):946-8. PubMed ID: 12497688
[TBL] [Abstract][Full Text] [Related]
23. Primary ovarian malignant mixed Müllerian tumor: a rare case report.
Jagtap SV; Jagtap SS; Gudur R; Billawaria S
Ther Adv Rare Dis; 2022; 3():26330040221107389. PubMed ID: 37180422
[TBL] [Abstract][Full Text] [Related]
24. Presence of a sarcomatous component outside the ovary is an adverse prognostic factor for primary ovarian malignant mixed mesodermal/mullerian tumors: a clinicopathologic study of 47 cases.
Kunkel J; Peng Y; Tao Y; Krigman H; Cao D
Am J Surg Pathol; 2012 Jun; 36(6):831-7. PubMed ID: 22588065
[TBL] [Abstract][Full Text] [Related]
25. Serous papillary adenocarcinoma of the female genital organs and invasive micropapillary carcinoma of the breast. Are WT1, CA125, and GCDFP-15 useful in differential diagnosis?
Moritani S; Ichihara S; Hasegawa M; Endo T; Oiwa M; Yoshikawa K; Sato Y; Aoyama H; Hayashi T; Kushima R
Hum Pathol; 2008 May; 39(5):666-71. PubMed ID: 18339419
[TBL] [Abstract][Full Text] [Related]
26. Invasive micropapillary carcinoma of the breast metastatic to the urinary bladder and endometrium: diagnostic pitfalls and review of the literature of tumors with micropapillary features.
Ramalingam P; Middleton LP; Tamboli P; Troncoso P; Silva EG; Ayala AG
Ann Diagn Pathol; 2003 Apr; 7(2):112-9. PubMed ID: 12715337
[TBL] [Abstract][Full Text] [Related]
27. Patients with a history of epithelial ovarian cancer presenting with a breast and/or axillary mass.
Karam AK; Stempel M; Barakat RR; Morrow M; Gemignani ML
Gynecol Oncol; 2009 Mar; 112(3):490-5. PubMed ID: 19101713
[TBL] [Abstract][Full Text] [Related]
28. Primary stromal sarcoma of breast with malignant fibrous histiocytoma-like features causing diagnostic dilemma on fine-needle aspiration cytology in a patient with squamous cell carcinoma of cervix: a case report.
Prasad PR; Kumar B; Kumar S; Basu D; Siddaraju N
Diagn Cytopathol; 2011 Mar; 39(3):223-8. PubMed ID: 20607805
[TBL] [Abstract][Full Text] [Related]
29. Coexistent choriocarcinoma and malignant mixed mesodermal tumor of the uterus.
Nguyen CP; Levi AW; Montz FJ; Bristow RE
Gynecol Oncol; 2000 Dec; 79(3):499-503. PubMed ID: 11104628
[TBL] [Abstract][Full Text] [Related]
30. Malignant mixed müllerian tumor with malignant neuroectodermal components (teratoid carcinosarcoma) of the ovary: Report of a case with clinicopathologic findings.
Matsuura Y; Kitajima M; Hachisuga T; Tanimoto A; Okura N; Kihara I
J Obstet Gynaecol Res; 2010 Aug; 36(4):907-11. PubMed ID: 20666968
[TBL] [Abstract][Full Text] [Related]
31. [A malignant mixed mesodermal tumor of the ovary].
Nakata Y; Morita M; Mori Y
Gan No Rinsho; 1990 Oct; 36(12):2210-7. PubMed ID: 2172588
[TBL] [Abstract][Full Text] [Related]
32. Bilateral ovarian malignant mixed Mullerian tumor in a dog.
Antuofermo E; Cocco R; Borzacchiello G; Burrai GP; Meloni F; Bonelli P; Pirino S; Cossu-Rocca P; Bosincu L
Vet Pathol; 2009 May; 46(3):453-6. PubMed ID: 19176505
[TBL] [Abstract][Full Text] [Related]
33. Metastatic ovarian Sertoli-cell tumor: FNA findings with immunohistochemistry.
Watson B; Siegel CL; Ylagan LR
Diagn Cytopathol; 2003 Nov; 29(5):283-6. PubMed ID: 14595797
[TBL] [Abstract][Full Text] [Related]
34. Primary and metastatic ovarian cancer in patients with prior breast carcinoma. Pre-operative markers and treatment results.
Tserkezoglou A; Kontou S; Hadjieleftheriou G; Apostolikas N; Vassilomanolakis M; Sikiotis K; Salamalekis E; Tseke P; Magiakos G
Anticancer Res; 2006; 26(3B):2339-44. PubMed ID: 16821613
[TBL] [Abstract][Full Text] [Related]
35. Carcinoma (malignant mixed müllerian [mesodermal] tumor) of the uterus and ovary. Correlation of clinical, pathologic, and immunohistochemical features in 29 cases.
Costa MJ; Khan R; Judd R
Arch Pathol Lab Med; 1991 Jun; 115(6):583-90. PubMed ID: 1710102
[TBL] [Abstract][Full Text] [Related]
36. Atypical sigmoid metastasis from a high-grade mixed adenocarcinoma of the ovary.
Zighelboim I; Broaddus R; Ramirez PT
Gynecol Oncol; 2004 Sep; 94(3):850-3. PubMed ID: 15350388
[TBL] [Abstract][Full Text] [Related]
37. Ovarian mature teratomas with mucinous epithelial neoplasms: morphologic heterogeneity and association with pseudomyxoma peritonei.
McKenney JK; Soslow RA; Longacre TA
Am J Surg Pathol; 2008 May; 32(5):645-55. PubMed ID: 18344868
[TBL] [Abstract][Full Text] [Related]
38. [Mixed uterine mesodermal sarcoma in the population of southern Israel in the years 1996-1971--clinical and pathological characteristics].
Ariad S; Rabinovitz A; Yanai-Inbar I; Piura B
Harefuah; 1998 Jan; 134(2):93-6, 159. PubMed ID: 9517289
[TBL] [Abstract][Full Text] [Related]
39. Primary ovarian mucinous tumors with signet ring cells: report of 3 cases with discussion of so-called primary Krukenberg tumor.
McCluggage WG; Young RH
Am J Surg Pathol; 2008 Sep; 32(9):1373-9. PubMed ID: 18670351
[TBL] [Abstract][Full Text] [Related]
40. The expression of epidermal growth factor receptor, HER-2/Neu, p53, and Ki-67 antigen in uterine malignant mixed mesodermal tumors and adenosarcoma.
Swisher EM; Gown AM; Skelly M; Ek M; Tamimi HK; Cain JM; Greer BE; Muntz HG; Goff BA
Gynecol Oncol; 1996 Jan; 60(1):81-8. PubMed ID: 8557233
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
